Achmea Investment Management B.V. Novo Cure LTD Transaction History

Achmea Investment Management B.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $278,193 - $390,905	4,625 New	4,625 $383,000
Q4 2021 Feb 10, 2022	SELL	$75.08 - $121.99 $347,245 - $564,203	-4,625 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $34,037 - $57,003	-293 Reduced 5.96%	4,625 $538,000
Q2 2021 Aug 06, 2021	BUY	$130.4 - $225.58 $60,636 - $104,894	465 Added 10.44%	4,918 $1.09 Million
Q4 2020 Feb 22, 2021	BUY	$112.16 - $174.14 $499,448 - $775,445	4,453 New	4,453 $771,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

Stay updated on Achmea Investment Management B.V. with notifications on news.